Brain tumors remain among the most challenging conditions in modern medicine. Due to their complexity and location, many of them are difficult to access, even with the most advanced surgical and ...
Ivonescimab alone or combined with chemotherapy led to intracranial responses among 34% of patients with brain metastases at baseline – 23% achieved a complete response All patients who did not ...
Development and validation of a clinical risk score for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO Resect group. This is an ASCO Meeting Abstract from the 2024 ASCO ...
A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in ...
A lecture under the auspices of the Cancer Commission of Harvard University, Feb. 25, 1909. Select the format you want to export the citation of this publication.
In a recent study published in the journal BMJ, a team of French researchers investigated the association between progestogen use and the risk of benign central nervous system tumors such as ...
The contraceptive injection Depo-Provera and two drugs used for menopause relief could be linked to a heightened risk for brain tumors in some women, a new study warns. Depo-Provera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results